ArticleNoro psikiyatri arsivi2026
Retrospective Review of 56 Patients with Sensory Ganglionopathy.
Article in Noro psikiyatri arsivi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sensory ganglionopathy (SG) is a rare and specific subgroup of the peripheral nervous system diseases. Electrophysiology shows a widespread amplitude decrease in sensory nerve action potential (SNAP) or absence of SNAPs in SG. SG diagnosis has a special importance in the context of etiology. We aimed to contribute to diagnosing SG as early as possible with the help of other supportive diagnostic work-up without the need for invasive methods by reviewing data of patients with electrophysiologically diagnosed SG. Methods: The medical records of 56 patients with SG diagnosed by electrodiagnostic (EDx) tests were reviewed. EDx findings were compared with our laboratory normal values. Also EDx findings of patients with 23 pure SG patients and 9 SG with motor axonal involvement were analyzed. Results: Etiology was determined in 35 (62.5%) of all patients besides a considerable idiopathic preponderance (n=14; 25%). Comparison of ulnar nerve DMLs of 23 pure SG patients and 9 SG with motor axonal involvement patients, was not statistically significant (p=0.064). Needle EMG findings of lower extremity were grade 1 in 52.9% and grade 3 in 5.8%. Of the patients who underwent upper extremity needle EMG, grade 1 was detected in 53.8% and grade 3 was detected in 7.6%. Conclusion: In order to diagnose SG as early as possible without the need for invasive methods and to elucidate its etiology, a thorough electrophysiological screening should be performed with the help of other supportive diagnostic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.